The last word to new FDA draft guidance for cancer clinical trial eligibility criteria for patients with incurable cancer

被引:0
|
作者
Lythgoe, Mark P. [1 ]
Prasad, Vinay [2 ]
机构
[1] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, Du Cane Rd, London W12 0HS, England
[2] Univ Calif San Francisco, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
来源
JOURNAL OF CANCER POLICY | 2022年 / 31卷
关键词
D O I
10.1016/j.jcpo.2022.100322
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Analysis of Temporal Constraints in Qualitative Eligibility Criteria of Cancer Clinical Studies
    He, Zhe
    Chen, Zhiwei
    Bian, Jiang
    2016 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2016, : 717 - 722
  • [42] Use of modernized eligibility criteria in pancreatic cancer clinical trials.
    Riner, Andrea N.
    Freudenberger, Devon Clemons
    Herremans, Kelly M.
    Neal, Daniel W.
    Vudatha, Vignesh
    George, Thomas J.
    Trevino, Jose G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] Decision support for clinical trial eligibility determination in breast cancer
    Ohno-Machado, L
    Wang, SJ
    Mar, P
    Boxwala, AA
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 1999, : 340 - 344
  • [44] Adjuvant treatment and outcomes in patients with stage III colon cancer (CC) who do not fit clinical trial eligibility criteria (CTEC)
    Javaheri, Khodadad Rasool
    Kennecke, Hagen F.
    Renouf, Daniel John
    Lim, Howard John
    Hsu, Tina
    Speers, Caroline
    Goktepe, Ozge
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [45] Attitudes of patients with incurable cancer toward medical treatment in the last phase of life
    Voogt, E
    van der Heide, A
    Rietjens, JAC
    van Leeuwen, AE
    Visser, AP
    van der Rijt, CCD
    van der Maas, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 2012 - 2019
  • [46] Phenotyping of clinical trial eligibility text from cancer studies into computable criteria in electronic health records.
    Mai, Yun
    Lee, Kyeryoung
    Liu, Zongzhi
    Ma, Meng
    Gilman, Christopher
    Li, Minghao
    Zhang, Mingwei
    Li, Zhiqiang
    Fink, Marc
    Mullaney, Tommy
    Prentice, Tony
    Ghosh, Krish
    Makosiej, Frank
    Pan, Qi
    Chen, Rong
    Schadt, Eric
    Wang, Xiaoyan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Clinical Trial Eligibility and Enrollment among Breast Cancer Patients at an Academic NCI designated Cancer Center: implications for understanding trial disparities
    Reh, Nicole
    Caston, Nicole
    Williams, Courtney
    Rocque, Gabrielle
    Gutnik, Lily
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S90 - S90
  • [48] Clinical & nutritional determinants of quality of life in patients with incurable cancer
    Daly, L. E.
    Sullivan, E. S.
    Dolan, R.
    Bhuachalla, E. B. Ni
    Cushen, S. J.
    Fallon, M.
    Simmons, C.
    McMillan, D. C.
    Laird, B.
    Ryan, A. M.
    Power, D. G.
    ANNALS OF ONCOLOGY, 2019, 30
  • [49] Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients
    Lee, Eudocia Q.
    Weller, Michael
    Sul, Joohee
    Bagley, Stephen J.
    Sahebjam, Solmaz
    van den Bent, Martin
    Ahluwalia, Manmeet
    Campian, Jian L.
    Galanis, Evanthia
    Gilbert, Mark R.
    Holdhoff, Matthias
    Lesser, Glenn J.
    Lieberman, Frank S.
    Mehta, Minesh P.
    Penas-Prado, Marta
    Schreck, Karisa C.
    Strowd, Roy E.
    Vogelbaum, Michael A.
    Walbert, Tobias
    Chang, Susan M.
    Nabors, L. Burt
    Grossman, Stuart
    Reardon, David A.
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2020, 22 (05) : 601 - 612
  • [50] Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer
    Rowe, Elizabeth J.
    Shugg, Tyler
    Ly, Reynold C.
    Philips, Santosh
    Rosenman, Marc B.
    Callaghan, John T.
    Radovich, Milan
    Overholser, Brian R.
    Schneider, Bryan P.
    Tisdale, James E.
    Skaar, Todd C.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9